Takayuki Shibusawa Selected Research

Takayuki Shibusawa Research Topics

4	Critical Illness (Critically Ill) 09/2023 - 01/2021
3	Heart Arrest (Cardiac Arrest) 01/2023 - 07/2016
3	Wounds and Injuries (Trauma) 03/2017 - 03/2016
2	COVID-19 01/2022 - 01/2022
2	Post-Cardiac Arrest Syndrome 09/2020 - 07/2016
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Shock 11/2021
1	Burns 02/2021
1	Coma (Comas) 09/2020
1	Hemostatic Disorders 09/2016
1	Acidosis 09/2016
1	Hypothermia 09/2016

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Fibrinogen (Factor I)FDA Link 03/2017 - 03/2016
2	Oxygen (Dioxygen)IBA 01/2023 - 02/2021
2	CytokinesIBA 11/2021 - 09/2020
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2021
2	HydrogenIBA 09/2020 - 07/2016
2	Indicators and Reagents (Reagents)IBA 09/2016 - 03/2016
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	InterleukinsIBA 11/2021
1	FibrinIBA 09/2016
1	fibrin fragment D (D-dimer)IBA 03/2016

1	Laparotomy 09/2023
1	Resuscitation 01/2023
1	Therapeutics 01/2023
1	Artificial Respiration (Mechanical Ventilation) 02/2021
1	Critical Care (Surgical Intensive Care) 03/2017